ALLERMI Trademark

Trademark Overview

On Thursday, March 16, 2023, a trademark application was filed for ALLERMI with the United States Patent and Trademark Office. The USPTO has given the ALLERMI trademark a serial number of 97843222. The federal status of this trademark filing is REGISTERED as of Tuesday, November 5, 2024. This trademark is owned by Allermi, Inc.. The ALLERMI trademark is filed in the Pharmaceutical Products category with the following description:

Allergy medications for human use; nasal spray preparations for human use
allermi

General Information

Serial Number97843222
Word MarkALLERMI
Filing DateThursday, March 16, 2023
Status700 - REGISTERED
Status DateTuesday, November 5, 2024
Registration Number7560594
Registration DateTuesday, November 5, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements

Goods and ServicesAllergy medications for human use; nasal spray preparations for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, April 8, 2023
Primary Code005
First Use Anywhere DateFriday, December 31, 2021
First Use In Commerce DateThursday, June 30, 2022

Trademark Owner History

Party NameAllermi, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94121
Party NameAllermi, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94121
Party NameAllermi, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94121

Trademark Events

Event DateEvent Description
Monday, March 20, 2023NEW APPLICATION ENTERED
Saturday, April 8, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 13, 2023ASSIGNED TO EXAMINER
Tuesday, December 19, 2023NON-FINAL ACTION WRITTEN
Tuesday, December 19, 2023NON-FINAL ACTION E-MAILED
Tuesday, December 19, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 22, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 2, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, April 11, 2024EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, April 16, 2024TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, May 22, 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, June 3, 2024ASSIGNED TO PETITION STAFF
Monday, June 3, 2024CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, July 2, 2024USE AMENDMENT FILED
Tuesday, July 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 2, 2024TEAS STATEMENT OF USE RECEIVED
Saturday, August 31, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, October 3, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, October 3, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 5, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, November 5, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Saturday, August 31, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords

allermi human preparations spray nasal allergy medications